The FDA named Dexcom its first TEMPO participant, allowing digital health devices to reach Medicare patients before authorisation in exchange for real-world data.

Under the TEMPO pilot program, Dexcom can receive Medicare reimbursement when seniors receive care from their software.

The FDA named Dexcom its first TEMPO participant, allowing digital health devices to reach Medicare patients before authorisation in exchange for real-world data.